A program designed to conduct drug development clinical trials for a psychedelic drug in Texas hit a road bump after the ...
Yoga combines physical postures, breathing exercises, and meditation in a way that has shown promise in reducing stress ...
Discover how National University Hospital (NUH) integrates research and care to lead Singapore’s healthcare. See our latest ...
April 01, 2026 - PRESSADVANTAGE - As global clinical research and cross-border healthcare operations continue to ...
Corti, maker of AI foundation models for healthcare, has released a new agentic model for medical coding that it says ...
Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
The Texas Tribune on MSN
Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help
The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for FDA approval.
Clinical AI, a healthcare artificial intelligence company focused on modernizing clinical trial operations, today announced that MAIA(TM) Prescreening is now available on Google Cloud Marketplace, ...
Artificial intelligence has already proven it can perform specific medical tasks, such as interpreting X-rays or flagging ...
Examining why medical AI is concentrated in elite systems while billions lack access, and how inclusive, scalable solutions ...
An analysis of AI-powered devices that received FDA's "breakthrough" label shows a preference for big-picture, multi-problem ...
A significant percentage of older adults had improvements in chronic pain with medical cannabis use at 12 and 24 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results